Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
China · Delayed Price · Currency is CNY 8.78
+0.07 (0.80%)
Jul 30, 2026, 3:00 PM CST
Tibet Weixinkang Medicine Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,162 | 1,136 | 1,300 | 1,323 | 1,399 | 1,034 |
Revenue Growth | -9.09% | -12.65% | -1.70% | -5.43% | 35.30% | 44.43% |
Gross Profit Gross Profit Growth | 710.22 | 693.34 | 695.98 | 671.41 | 726.48 | 530.92 |
Operating Income Operating Income Growth | 208.24 | 219.67 | 222.43 | 145.07 | 154.54 | 92.92 |
Net Income Net Income Growth | 216.65 | 232.85 | 246.17 | 214.02 | 176.96 | 95.91 |
Earnings Per Share EPS Growth | 0.50 | 0.54 | 0.57 | 0.50 | 0.41 | 0.23 |
EPS Growth | -8.68% | -5.26% | 14.00% | 21.95% | 78.26% | 64.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,053 | 982.22 | 1,019 | 894.75 | 806.32 | 711.55 |
Total Debt Total Debt Growth | 11.81 | 11.2 | 5.27 | 7.68 | 5.79 | 4.81 |
Net Cash (Debt) Net Cash Growth | 1,041 | 971.02 | 1,014 | 887.07 | 800.53 | 706.73 |
Net Cash Growth | -0.70% | -4.25% | 14.33% | 10.81% | 13.27% | 22.80% |
Net Cash Per Share Net Cash Per Share Growth | 2.41 | 2.25 | 2.35 | 2.07 | 1.85 | 1.69 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 223.03 | 185.53 | 372.78 | 241.12 | 246.15 | 170.69 |
Capital Expenditures CapEx Growth | -85.59 | -83.92 | -58.18 | -70.81 | -77.69 | -55.6 |
Free Cash Flow Free Cash Flow Growth | 137.44 | 101.62 | 314.61 | 170.3 | 168.46 | 115.09 |
Free Cash Flow Growth | -43.18% | -67.70% | 84.73% | 1.09% | 46.37% | 45.04% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 61.12% | 61.05% | 53.53% | 50.76% | 51.95% | 51.37% |
Operating Margin | 17.92% | 19.34% | 17.11% | 10.97% | 11.05% | 8.99% |
Pretax Margin | 23.20% | 24.97% | 21.27% | 16.32% | 13.04% | 11.05% |
Profit Margin | 18.64% | 20.50% | 18.93% | 16.18% | 12.65% | 9.28% |
FCF Margin | 11.83% | 8.95% | 24.20% | 12.88% | 12.04% | 11.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.327 | 0.327 | 0.342 | 0.285 | 0.235 | 0.160 |
Dividend Per Share Growth | -4.39% | -4.39% | 20.00% | 21.28% | 46.88% | 68.42% |
Dividend Yield | 3.84% | 3.18% | 3.62% | 3.02% | 1.66% | 1.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.38 | 19.53 | 17.59 | 21.21 | 39.15 | 42.23 |
P/FCF Ratio | 27.40 | 44.76 | 13.76 | 26.65 | 41.12 | 35.20 |
PS Ratio | 3.24 | 4.01 | 3.33 | 3.43 | 4.95 | 3.92 |